NRx Pharmaceuticals (NASDAQ:NRXP – Get Free Report)‘s stock had its “buy” rating reaffirmed by D. Boral Capital in a research report issued to clients and investors on Monday,Benzinga reports.
$ 0.07 USD-0.01-7.47% ...
TVGN Tevogen Bio Holdings Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback